News | Mammography | September 17, 2015

Hologic’s Genius 3-D Mammography Continues to Lead U.S. Breast Tomosynthesis Market

KLAS Research finds Hologic stands out among mammography providers for technology innovation, high image quality and C-View dose-reduction technology

Hologic, Genius 3-D Mammography, KLAS Research, U.S. breast tomosynthesis market, C-View

Selenia Dimensions system with Genius 3-D Mammography image courtesy of Hologic.
 

September 17, 2015 — Hologic Inc. announced that U.S. mammography providers gave the company and its Genius 3-D Mammography exams top scores in a new study by KLAS Research, titled Women’s Imaging 2015: Are New Technologies Delivering Promised Benefits?

In the study, mammography providers scored Hologic highest in all 11 performance measures evaluated by KLAS.  For example:

  • 95 percent of users said they would buy from Hologic again; and
  • 67 percent of users said Hologic was their best mammography vendor.

The researchers noted that Hologic 3-D Mammography stands out for technology innovation and high image quality, and that its C-View software is strengthening satisfaction and encouraging adoption. 

The KLAS study found significant movement in the mammography space thanks to the advent of breast tomosynthesis technology. For example, 65 percent of the providers surveyed planned to invest in breast tomosynthesis technology during the next two years, up from 57 percent in 2014. The study notes that many respondents who said they did not intend to purchase had already upgraded to tomosynthesis.

Clinical studies have shown that a Hologic Genius 3-D Mammography exam using the company’s low-dose software is superior to 2-D exams alone for all breast types, improving diagnostic accuracy while also reducing recalls. With C-View software, facilities can offer a better exam at an equivalent dose to 2-D alone.

For more information: www.hologic.com

Related Content

PET Scans Show Biomarkers Could Spare Some Breast Cancer Patients from Chemotherapy
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
Sponsored Content | Videos | Enterprise Imaging | March 15, 2019
As a VNA, GE Healthcare Ce
Canon Medical Introduces Entry-Level Aquilion Start CT
News | Computed Tomography (CT) | March 14, 2019
Canon Medical Systems Europe B.V. introduced the all-new Aquilion Start computed tomography (CT) system to the European...
Hologic Receives CE Mark for Three-in-One Omni Hysteroscope
News | Endoscopes | March 14, 2019
Hologic Inc. announced it has received a CE mark in Europe for its Omni hysteroscope, a three-in-one modular scope with...
Siemens Healthineers Debuts Cardiovascular Edition of Somatom go.Top CT
News | Computed Tomography (CT) | March 14, 2019
Siemens Healthineers will introduced the Somatom go.Top Cardiovascular Edition, a new version of its established...
Esaote Introduces MyLab X8 Ultrasound Platform
News | Ultrasound Imaging | March 13, 2019
Esaote announced the launch of MyLab X8, a high-performance, versatile ultrasound platform to support hospitals and...
CT, Mammograms Offer Clues to Preventing Heart Problems After Cancer Treatment
News | Cardio-oncology | March 13, 2019
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...